We recently published 10 Stocks With Effortless Double-, Triple-Digit Gains. Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) was ...

We recently published 10 Stocks Delivering Double-Digit Gains Effortlessly; 4 Hit Highs. Corvus Pharmaceuticals Inc.

Sanofi (EPA: SASY) has announced encouraging late-stage clinical trial results for its investigational drug amlitelimab, ...

Corvus Pharma reports encouraging data for its eczema drug soquelitinib, showing strong skin improvement and no serious ...

A Geelong mum-of-three has searched far and wide for a uniform her eczema-suffering son can wear without triggering painful ...

FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly announced on Friday safety ...

A clinical review breaks down the latest best practices for managing severe atopic dermatitis (AD) in pregnancy. The review, which appears in Clinical Medicine, was developed by a team of British ...

Kim H. from Nevada writes: “I read an article you wrote about how gut health affects the brain and other parts of the body. Our 19-year-old son has severe eczema and is living in Hong Kong. We thought ...

The US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate to severe atopic dermatitis (AD) in children 12-17 years old, ...

Treatment options for severe chronic hand eczema are limited and carry troublesome adverse effects. Delgocitinib cream had superior efficacy compared with oral alitretinoin for this patient population ...

Infants diagnosed with severe eczema or an egg allergy may be more likely to develop peanut allergy (PA), according to baseline results from the Learning Early About Peanut Allergy (LEAP) study. The ...